DIEBOLD NIXDORF, INC, 10-Q filed on 4/30/2026
Quarterly Report
v3.26.1
Cover - shares
3 Months Ended
Mar. 31, 2026
Apr. 22, 2026
Cover [Abstract]    
Document Type 10-Q  
Document Quarterly Report true  
Document Period End Date Mar. 31, 2026  
Document Transition Report false  
Entity File Number 1-4879  
Entity Registrant Name Diebold Nixdorf, Incorporated  
Entity Incorporation, State or Country Code DE  
Entity Tax Identification Number 34-0183970  
Entity Address, Address Line One 350 Orchard Avenue NE  
Entity Address, City or Town North Canton  
Entity Address, State or Province OH  
Entity Address, Postal Zip Code 44720-2556  
City Area Code 330  
Local Phone Number 490-4000  
Title of 12(b) Security Common Stock, $0.01 par value per share  
Trading Symbol DBD  
Security Exchange Name NYSE  
Entity Current Reporting Status Yes  
Entity Interactive Data Current Yes  
Entity Filer Category Large Accelerated Filer  
Entity Small Business false  
Entity Emerging Growth Company false  
Entity Shell Company false  
Entity Bankruptcy Proceedings, Reporting Current true  
Entity Common Stock, Shares Outstanding   34,628,392
Entity Central Index Key 0000028823  
Current Fiscal Year End Date --12-31  
Document Fiscal Year Focus 2026  
Document Fiscal Period Focus Q1  
Amendment Flag false  
v3.26.1
STATEMENT OF FINANCIAL POSITION (UNAUDITED) - USD ($)
$ in Millions
Mar. 31, 2026
Dec. 31, 2025
ASSETS    
Cash, cash equivalents and restricted cash $ 373.6 $ 387.3
Short-term investments 0.0 29.1
Trade receivables, net of allowances of $4.0 and $6.0, respectively 597.0 609.4
Inventories (Note 2) 553.1 521.0
Prepaid expenses 31.1 50.9
Other current assets 245.3 189.1
Total current assets 1,800.1 1,786.8
Property, plant and equipment, net (Note 3) 293.0 286.0
Deferred income taxes 103.3 105.0
Goodwill (Note 4) 632.1 642.4
Customer relationships and other intangible assets, net (Note 4) 764.6 792.4
Other assets 236.8 241.8
Total assets 3,829.9 3,854.4
LIABILITIES    
Accounts payable 482.6 431.1
Deferred revenue 359.4 325.8
Payroll and other benefits liabilities 165.6 201.6
Other current liabilities 396.4 413.0
Total current liabilities 1,404.0 1,371.5
Long-term debt (Note 7) 939.4 938.5
Pensions, post-retirement and other benefits 115.9 120.4
Deferred income taxes 197.0 200.7
Other liabilities 147.4 118.5
Total liabilities 2,803.7 2,749.6
EQUITY    
Common stock (Note 9) 0.4 0.4
Paid-in-capital 1,064.0 1,060.5
Retained earnings 96.9 91.9
Treasury shares, at cost (Note 9) (191.1) (130.7)
Accumulated other comprehensive income (Note 9) 52.7 77.8
Total Diebold Nixdorf shareholders' equity 1,022.9 1,099.9
Noncontrolling interests 3.3 4.9
Total equity 1,026.2 1,104.8
Total liabilities and equity $ 3,829.9 $ 3,854.4
v3.26.1
STATEMENT OF FINANCIAL POSITION (UNAUDITED) (Parenthetical) - USD ($)
$ in Millions
Mar. 31, 2026
Dec. 31, 2025
Current assets    
Allowance for doubtful accounts $ 4.0 $ 6.0
v3.26.1
STATEMENT OF EARNINGS (UNAUDITED) - USD ($)
shares in Millions, $ in Millions
3 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Net sales    
Total revenues (Note 5) $ 891.8 $ 841.1
Cost of sales    
Total cost of sales 678.7 638.7
Gross profit 213.1 202.4
Selling and administrative expense 157.2 151.8
Research, development and engineering expense 22.1 22.7
Other operating expense (income) 1.1 (1.7)
Total costs and expenses 180.4 172.8
Operating profit 32.7 29.6
Other income (expense)    
Interest income 2.9 1.5
Interest expense (23.3) (21.5)
Foreign exchange, net (2.4) (18.5)
Miscellaneous, net 2.5 1.5
Income (loss) before taxes 12.4 (7.4)
Income tax expense (benefit) (Note 8) 5.7 (2.2)
Equity in loss of unconsolidated subsidiaries, net (1.2) (2.3)
Net income (loss) 5.5 (7.5)
Net income attributable to noncontrolling interests 0.5 0.8
Net income (loss) attributable to Diebold Nixdorf $ 5.0 $ (8.3)
Basic weighted-average shares outstanding (in shares) 35.1 37.6
Diluted weighted-average shares outstanding (in shares) 35.7 37.6
Net income (loss) attributable to Diebold Nixdorf    
Basic earnings (loss) per share (in dollars per share) $ 0.14 $ (0.22)
Diluted earnings (loss) per share (in dollars per share) $ 0.14 $ (0.22)
Services    
Net sales    
Total revenues (Note 5) $ 536.8 $ 508.5
Cost of sales    
Total cost of sales 416.1 391.3
Products    
Net sales    
Total revenues (Note 5) 355.0 332.6
Cost of sales    
Total cost of sales $ 262.6 $ 247.4
v3.26.1
STATEMENT OF CASH FLOWS (UNAUDITED) - USD ($)
$ in Millions
3 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Cash Provided by (Used in) Operating Activity, Including Discontinued Operation [Abstract]    
Net income (loss) $ 5.5 $ (7.5)
Adjustments to reconcile net income (loss) to cash flow provided (used) by operating activities:    
Depreciation and amortization 31.4 33.9
Amortization of deferred financing costs into interest expense 1.7 1.5
Share-based compensation 3.2 3.0
Deferred income taxes 1.3 (2.0)
(Gain) loss on foreign currency translation (0.6) 17.3
Other 1.4 (1.4)
Changes in certain assets and liabilities:    
Trade receivables 3.8 0.4
Inventories (38.7) (4.8)
Accounts payable 59.0 (23.5)
Deferred revenue 61.0 55.2
Sales tax and net value added tax (30.1) (11.5)
Accrued salaries, wages and commissions (28.7) (26.0)
Certain other assets and liabilities (38.5) (18.9)
Net cash provided by operating activities 31.7 15.7
Cash Provided by (Used in) Investing Activity, Including Discontinued Operation [Abstract]    
Capital expenditures (5.6) (7.9)
Capitalized software development (5.4) (1.7)
Proceeds from maturities of investments 29.1 80.5
Payments for purchases of investments 0.0 (70.9)
Other investments 2.1 0.0
Net cash provided by investing activities 20.2 0.0
Cash Provided by (Used in) Financing Activity, Including Discontinued Operation [Abstract]    
Distributions to noncontrolling interest holders 0.0 (2.0)
Treasury share activity (60.4) (9.6)
Other (1.8) (1.2)
Net cash used by financing activities (62.2) (12.8)
Effect of exchange rate changes on cash, cash equivalents and restricted cash (3.4) 6.0
Change in cash, cash equivalents and restricted cash (13.7) 8.9
Cash, cash equivalents and restricted cash at the beginning of the period 387.3 311.3
Cash, cash equivalents and restricted cash at the end of the period 373.6 320.2
Supplemental Cash Flow Information [Abstract]    
Cash paid for: Income taxes 6.0 6.7
Cash paid for: Interest $ 37.1 $ 21.4
v3.26.1
STATEMENT OF COMPREHENSIVE INCOME (LOSS) (UNAUDITED) - USD ($)
$ in Millions
3 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Net income (loss) $ 5.5 $ (7.5)
Other comprehensive income (loss), net of tax    
Translation adjustment (29.8) 69.8
Pension and other post-retirement benefits net actuarial gain (loss) amortized, tax of $(0.3) and $(0.3), respectively 0.7 (0.6)
Other (0.3) (0.3)
Other comprehensive income (loss), net of tax (27.2) 68.9
Comprehensive income (loss) (21.7) 61.4
Less: Comprehensive income (loss) attributable to noncontrolling interests (1.6) 0.6
Comprehensive income (loss) attributable to Diebold Nixdorf (20.1) 60.8
Foreign currency hedges    
Other comprehensive income (loss), net of tax    
Foreign currency hedges (net of tax of $(0.7) and $— , respectively) $ 2.2 $ 0.0
v3.26.1
STATEMENT OF COMPREHENSIVE INCOME (LOSS) (UNAUDITED) (Parenthetical) - USD ($)
$ in Millions
3 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Net actuarial gain (loss) amortized, tax $ (0.3) $ (0.3)
Foreign currency hedges    
Hedges, tax $ (0.7) $ 0.0
v3.26.1
STATEMENT OF CHANGES IN SHAREHOLDERS' EQUITY (UNAUDITED) - USD ($)
$ in Millions
Total
Diebold Nixdorf Shareholders' equity
Common stock
Accumulated other comprehensive income
Paid-in-capital
Retained earnings
Treasury shares
Noncontrolling interests
Beginning balance at Dec. 31, 2024     $ 0.4 $ (117.9) $ 1,048.4 $ (1.1) $ 0.0 $ 8.4
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net income (loss) $ (7.5)         (8.3)   0.8
Other comprehensive income 68.9     69.1       (0.2)
Share-based compensation     0.0   3.0      
Purchases             (9.6)  
Distributions to non-controlling interest holders, net               (2.0)
Ending balance at Mar. 31, 2025 991.0 $ 984.0 0.4 (48.8) 1,051.4 (9.4) (9.6) 7.0
Beginning balance at Dec. 31, 2025 1,104.8   0.4 77.8 1,060.5 91.9 (130.7) 4.9
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net income (loss) 5.5         5.0   0.5
Other comprehensive income (27.2)     (25.1)       (2.1)
Share-based compensation     0.0   3.5      
Purchases (55.0)           (60.4)  
Distributions to non-controlling interest holders, net               0.0
Ending balance at Mar. 31, 2026 $ 1,026.2 $ 1,022.9 $ 0.4 $ 52.7 $ 1,064.0 $ 96.9 $ (191.1) $ 3.3
v3.26.1
Basis of Presentation
3 Months Ended
Mar. 31, 2026
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
Basis of Presentation Basis of Presentation. The accompanying unaudited condensed consolidated financial statements of Diebold Nixdorf, Incorporated and its subsidiaries (collectively, the Company) have been prepared in accordance with the instructions to Form 10-Q and therefore do not include all information and footnotes necessary for a fair presentation of financial position, results of operations and cash flows in conformity with accounting principles generally accepted in the United States (U.S. GAAP); however, such information reflects all adjustments that are, in the opinion of management, necessary for a fair statement of the results for the interim periods presented. The Company has reclassified the presentation of certain prior-year information to conform to the current presentation. The condensed consolidated financial statements should be read in conjunction with the consolidated financial statements and notes contained in the Company’s Annual Report on Form 10-K for the year ended December 31, 2025. In addition, some of the Company’s statements in this Quarterly Report on Form 10-Q may involve risks and uncertainties that could significantly impact expected future results. The results for interim periods are not necessarily indicative of results for the entire year.
v3.26.1
Inventories
3 Months Ended
Mar. 31, 2026
Inventory Disclosure [Abstract]  
Inventories Inventories. Major classes of inventories are summarized as follows:
March 31, 2026December 31, 2025
Raw materials and work in process$181.2 $173.3 
Finished goods179.0 154.0 
Total product inventories360.2 327.3 
Service parts192.9 193.7 
Total inventories$553.1 $521.0 
v3.26.1
Property, Plant and Equipment and Operating Leases
3 Months Ended
Mar. 31, 2026
Property, Plant and Equipment [Abstract]  
Property, Plant and Equipment and Operating Leases Property, Plant and Equipment and Operating Leases.
March 31, 2026December 31, 2025
Cost$224.8 $225.6 
Less accumulated depreciation(84.0)(81.0)
Right-of-use operating lease assets152.2 141.4 
Property, plant and equipment, net$293.0 $286.0 

Depreciation expense. Depreciation expense was $6.4 and $8.5 for the three months ended March 31, 2026 and 2025, respectively.

Operating lease liabilities. Our current operating lease liabilities, included in Other current liabilities in our Statement of Financial Position, were $55.4 and $51.8 as of March 31, 2026 and December 31, 2025, respectively. Our non-current operating lease liabilities, included in Other liabilities in our Statement of Financial Position, were $98.8 and $91.9 as of March 31, 2026 and December 31, 2025, respectively.
v3.26.1
Goodwill and Other Intangible Assets
3 Months Ended
Mar. 31, 2026
Goodwill and Intangible Assets Disclosure [Abstract]  
Goodwill and Other Intangible Assets Goodwill and Other Intangible Assets. Goodwill and intangibles are tested for impairment annually during the fourth quarter or earlier if a triggering event is identified. The changes in the carrying amount of goodwill for the three months ended March 31, 2026:
BankingRetailTotal
Goodwill, balance at January 1, 2026$490.9 $151.5 $642.4 
Currency translation adjustment(7.9)(2.4)(10.3)
Goodwill, balance at March 31, 2026
483.0 149.1 632.1 
The following summarizes information on Intangible assets by major category:
March 31, 2026December 31, 2025
Weighted-average remaining useful livesGross
Carrying
Amount
Accumulated
Amortization
Net
Carrying
Amount
Gross
Carrying Amount
Accumulated
Amortization
Net
Carrying
Amount
Customer relationships14.9 years$575.4 $(86.7)$488.7 $584.7 $(79.5)$505.2 
Trademarks and trade names15.7 years121.7 (17.5)104.2 123.3 (16.0)107.3 
Capitalized software development2.0 years79.8 (22.4)57.4 75.6 (18.3)57.3 
Technology know-how and development costs non-software and other3.6 years237.8 (123.5)114.3 240.8 (118.2)122.6 
Customer relationships and other intangible assets, net$1,014.7 $(250.1)$764.6 $1,024.4 $(232.0)$792.4 
The Company's total amortization expense, excluding that related to deferred financing costs, was $25.0 and $25.4 for the three months ended March 31, 2026 and 2025, respectively. The primary driver of the change in gross carrying amount was due to a decrease for currency translation of $15.2 and an increase in software development costs of $5.4
v3.26.1
Revenue Recognition
3 Months Ended
Mar. 31, 2026
Revenue from Contract with Customer [Abstract]  
Revenue Recognition Revenue Recognition. A performance obligation is a contractual promise to transfer a distinct good or service to the customer. A contract's transaction price is allocated to each distinct performance obligation and is recognized as revenue when (point in time) or as (over time) the performance obligation is satisfied. For both the three months ended March 31, 2026 and 2025, the revenue recognized by the Company included approximately 40% for products transferred at a point in time and 60% for products and services transferred over time.
Contract balances. The following table provides information about receivables and deferred revenue, which represent contract liabilities from contracts with customers:
Contract balance informationTrade receivablesContract liabilities
Balance at December 31, 2025$609.4 $325.8 
Balance at March 31, 2026$597.0 $359.4 

There have been $0.6 and $1.7 of impairment losses recognized as bad debt related to receivables or contract assets arising from the Company's contracts with customers during the three months ended March 31, 2026 and 2025, respectively.

As of December 31, 2025, the Company had $325.8 of deferred revenue constituting the remaining performance obligations that are unsatisfied (or partially unsatisfied). During the three months ended March 31, 2026, the Company recognized revenue of $102.8 related to the Company's deferred revenue balance at December 31, 2025.
v3.26.1
Segment Information
3 Months Ended
Mar. 31, 2026
Segment Reporting [Abstract]  
Segment Information Segment Information. The Company's reportable segment information below directly aligns with how the Chief Executive Officer, who is also the chief operating decision maker (CODM), regularly reviews results to make decisions, allocate resources, and assess performance. Revenue, costs, operating expenses and operating profit (loss), as disclosed herein, is consistent with the segment information used by the CODM and does not include corporate charges, asset impairment, restructuring and saving initiative charges, or other non-routine, unusual or infrequently occurring items, as the CODM does not regularly review and use such financial measures to make decisions, allocate resources and assess performance.
Segment revenue and cost of sales are from sales to external customers. Segment operating profit is defined as segment gross profit less expenses directly attributable to the segments. The Company does not allocate to its segments certain operating expenses which are managed at the headquarters level; that are not used in the management of the segments, not segment-specific, and impractical to allocate. Segment operating profit reconciles to consolidated loss before income taxes by deducting items that are not attributed to the segments and which are managed independently of segment results. Assets are not allocated to segments, and thus are not included in the assessment of segment performance, and consequently, we do not disclose total assets and depreciation and amortization expense by reportable operating segment.
The following tables present information regarding the Company’s segment performance and provide a reconciliation between segment operating profit and the consolidated income (loss) before taxes:
Three months ended March 31,
 20262025
Banking$620.7 $629.5 
Retail267.5 211.6 
Total net sales by segment$888.2 $841.1 
Banking455.6 468.1 
Retail207.1 159.8 
Total segment cost of sales$662.7 $627.9 
Banking165.1 161.5 
Retail60.4 51.7 
Total segment gross profit$225.5 $213.2 
Banking66.4 64.0 
Retail30.4 29.2 
Total segment SG&A and other operating expenses$96.8 $93.2 
Banking$98.7 $97.6 
Retail30.0 22.4 
Total segment operating profit$128.7 $120.0 
Corporate charges not allocated to segments(1)
$(67.8)$(72.1)
Restructuring and other saving initiative expenses(2)
(24.0)(20.0)
Non-core APMEA entity(3)
(6.7)— 
Net non-routine income(4)
2.5 1.7 
(96.0)(90.4)
Operating profit32.7 29.6 
Other expense, net(20.3)(37.0)
Income (loss) before taxes$12.4 $(7.4)
(1)    Corporate charges not allocated to segments include headquarter-based costs associated primarily with human resources, finance, IT and legal that are not directly attributable to a particular segment and are separately assessed by the CODM for purposes of making decisions.
(2)    Refer to Note 11 for further information regarding restructurings. Consistent with the historical reportable segment structure, restructuring and saving initiative costs are not assigned to the segments, and are separately analyzed by the CODM.
(3)    Non-core APMEA entity includes operational activity and impairment charges that the Company intends to wind down in 2026, including $3.6 of revenue for the three months ended March 31, 2026.
(4)    Net non-routine income consists of items that the Company has determined are non-routine in nature and not allocated to the reportable operating segments as they are not included in the measure used by the CODM to make decisions, allocate resources and assess performance.
The following table presents information regarding the Company’s segment net sales by service and product solution:
Three months ended March 31,
20262025
Services$391.1 $382.2 
Products233.1 247.3 
Total Banking624.2 629.5 
Services145.7 126.3 
Products121.9 85.3 
Total Retail267.6 211.6 
Total revenue $891.8 $841.1 
v3.26.1
Debt
3 Months Ended
Mar. 31, 2026
Debt Disclosure [Abstract]  
Debt Debt. Outstanding debt balances were as follows:
March 31, 2026December 31, 2025
2030 Senior Secured Notes$950.0 $950.0 
Other19.9 20.7 
Long-term debt$969.9 $970.7 
Long-term deferred financing fees(30.5)(32.2)
Total outstanding debt$939.4 $938.5 

2024 Refinancing Activities - Senior Secured Notes Due 2030 (the 2030 Senior Secured Notes). On December 18, 2024, the Company issued $950.0 in aggregate principal amount 7.75% Senior Secured Notes due 2030 to qualified institutional buyers in a private placement exempt from the registration requirements of the Securities Act of 1933. The 2030 Senior Secured Notes were issued at par.

Revolving Credit Agreement. On December 18, 2024, the Company entered into a credit agreement (the Credit Agreement) for a $310.0 revolving credit facility maturing on December 18, 2029 (the Revolving Credit Facility). Borrowings under the Revolving Credit Facility bear interest at an adjusted secured overnight financing rate plus a margin of 2.75% to 3.50% per annum or an adjusted base rate plus a margin of 1.75% to 2.50% per annum, in each case based on the consolidated first lien debt ratio of the Company and its restricted subsidiaries. As of March 31, 2026, no amounts were outstanding under the Revolving Credit Facility.

Below is a summary of financing information:
Financing FacilitiesInterest Rate
Index and Margin
Maturity/Termination DatesInitial Term (Years)
2030 Senior Secured Notes
7.75%
March 20305.25
Revolving Credit Facility(i)
SOFR + 2.75%-3.50%
December 20295.00
(i)SOFR with a floor of 0.0%     

The Company had various international uncommitted and non-utilized short-term lines of credit with borrowing limits aggregating to $14.5 and $8.5 as of March 31, 2026 and December 31, 2025. There were no outstanding borrowings on the short-term lines of credit as of March 31, 2026 or December 31, 2025. Short-term lines mature in less than one year and are used to support working capital.
v3.26.1
Income Taxes
3 Months Ended
Mar. 31, 2026
Income Tax Disclosure [Abstract]  
Income Taxes Income Taxes.
Three months ended March 31,
20262025
Income tax expense
$5.7 $(2.2)
Effective tax rate46.0 %29.7 %

The effective tax rate on the income from continuing operations was 46.0% and 29.7% for the three months ended March 31, 2026 and 2025, respectively. For all periods noted, the effective tax rate differed compared to the U.S. federal statutory rate due to expected jurisdictional mix of earnings, U.S. tax on foreign income and other expected permanent tax differences relative to pretax earnings. Additionally, for the three months ended March 31, 2026, the Company recorded a net discrete tax benefit, and for the three months ended March 31, 2025, the Company recorded a net discrete tax expense.
v3.26.1
Shareholders' Equity
3 Months Ended
Mar. 31, 2026
Equity [Abstract]  
Shareholders' Equity Shareholders' Equity. The following table summarizes the changes in the Company’s Accumulated Other Comprehensive Income (AOCI), net of tax, by component for the three months ended March 31, 2026 and 2025:
Accumulated Other Comprehensive Income (Loss)Three months ended March 31,
(in millions)20262025
Beginning balance$74.5 $(111.6)
Other comprehensive income before reclassifications(1)
(27.7)70.0 
Currency translation adjustments AOCI$46.8 $(41.6)
Beginning balance$(6.0)$(0.1)
Other comprehensive loss before reclassifications2.2 — 
Foreign currency hedges AOCI$(3.8)$(0.1)
Beginning balance$10.1 $(5.7)
Amounts reclassified from AOCI(2)
0.7 (0.6)
Pension and other post-retirement benefits$10.8 $(6.3)
Beginning balance$(0.8)$(0.5)
Other comprehensive loss before reclassifications(0.3)(0.3)
Other$(1.1)$(0.8)
AOCI at March 31$52.7 $(48.8)
(1) Other comprehensive income (loss) before reclassifications within the translation component excludes $2.1 and $0.2 translation amount attributable to noncontrolling interests for the three months ended March 31, 2026 and 2025, respectively.
(2) The total reclassification from AOCI included pension and post-retirement net actuarial gain (loss) of $0.7 and $(0.6) net of tax, for the three months ended March 31, 2026 and 2025, respectively.

Common stock. The Company's authorized common stock includes 45,000,000 shares, with a par value of $0.01 per share. As of March 31, 2026, 37,900,756 shares were issued and 34,751,349 shares were outstanding. As of December 31, 2025, 37,726,003 shares were issued and 35,384,690 shares were outstanding. The Company had 3,149,407 and 2,341,313 treasury shares as of March 31, 2026 and December 31, 2025, respectively. During the three months ended March 31, 2026 we repurchased 747,000 shares under the share repurchase program for $55.0, and incurred taxes and fees of $0.6. In addition, the Company repurchased 61,484 shares related to shares withheld for income taxes on vested share-based compensation for $4.8. The Company's share repurchase program does not obligate it to acquire any specific number of shares. Under the share repurchase program, shares may be purchased in the open market or otherwise, including under accelerated share repurchase programs or under plans complying with Rule 10b5-1 under the Exchange Act.
v3.26.1
Earnings (Loss) Per Share
3 Months Ended
Mar. 31, 2026
Earnings Per Share [Abstract]  
Earnings (Loss) Per Share Earnings (Loss) Per Share. The following table represents amounts used in computing earnings per share and the effect on the weighted-average number of shares of potential dilutive common stock:
Three months ended March 31,
20262025
Earnings used in basic and diluted earnings per share
Net income (loss)$5.5 $(7.5)
Net income attributable to noncontrolling interests0.5 0.8 
Net income (loss) attributable to Diebold Nixdorf$5.0 $(8.3)
Weighted-average common shares in basic earnings (loss) per share35.1 37.6 
Effect of dilutive shares(1)
0.6 — 
Weighted-average number of shares used in diluted earnings (loss) per share 35.7 37.6 
Net income (loss) attributable to Diebold Nixdorf
Basic earnings (loss) per share$0.14 $(0.22)
Diluted (loss) earnings per share$0.14 $(0.22)
Anti-dilutive shares
Anti-dilutive shares not used in calculating diluted weighted-average shares— 0.5 
(1)     Shares of 0.3 for the three months ended March 31, 2025 are excluded from the computation of diluted loss per share because the effects are anti-dilutive, due to the net loss position.
v3.26.1
Restructuring
3 Months Ended
Mar. 31, 2026
Restructuring and Related Activities [Abstract]  
Restructuring Restructuring. In the fourth quarter of 2025, the Company initiated its Operational Evolution Program (OEP). The OEP is meant to improve efficiency and streamline the organization structure of the Company. The total amount expected to be incurred in relation to the OEP is $95, which includes $28 and $17 related to our Banking and Retail segments, respectively. As of March 31, 2026, the Company has recognized total cumulative restructuring charges of $50.9, which includes $16.0 and $9.0 related to our Banking and Retail segments, respectively. The most significant expense primarily relates to headcount reduction. Total restructuring charges related to the OEP for the three months ended March 31, 2026 were $6.0 and $6.1 in our Banking and Retail segments, respectively, which includes costs related to a non-core business in APMEA.
Completed Plans. During the fourth quarter of 2023, the Company introduced its continuous improvement initiative, which focused on consistently innovating its solutions to support a better transaction experience for consumers at bank and retail locations while simultaneously streamlining cost structures and business processes through the integration of hardware, software and services. The Company completed this program in the fourth quarter of 2025. The most significant expense for the three months ended March 31, 2025 primarily relates to headcount reduction and redefining the organization structure in relation to the improvement process. Total restructuring charges for the three months ended March 31, 2025 for the Banking and Retail segments were $3.4 and $7.1, respectively. Total restructuring charges also includes corporate charges that are not allocated to the segments.

The following tables summarizes the impact of the Company’s restructuring charges on the Consolidated Statements of Earnings:
Three months ended March 31,
 20262025
Cost of sales – services$11.5 $10.5 
Cost of sales – products0.6 0.3 
Selling and administrative expense11.9 6.8 
Research, development and engineering expense— 2.4 
Total$24.0 $20.0 

The following table summarizes the Company’s severance accrual balance and related activity:
20262025
Beginning balance as of January 1$41.4 $15.9 
Severance accrual10.9 15.2 
Payout/Settlement(9.5)(11.0)
Other(0.1)0.1 
Ending balance as of March 31$42.7 $20.2 
v3.26.1
Financial Instruments and Fair Value
3 Months Ended
Mar. 31, 2026
Financial Instruments and Fair Value [Abstract]  
Financial Instruments and Fair Value Financial Instruments and Fair Value. The following table provides information about assets and liabilities not carried at fair value and excludes asset and liabilities without readily determinable fair value.
 March 31, 2026December 31, 2025
 Carrying amountEstimated fair valueCarrying amount (net)Estimated fair value
LiabilitiesBorrowings (Note 7)$969.9 $1,007.9 $970.7 $1,030.1 

Assets and liabilities that are reflected in the accompanying condensed consolidated financial statements at fair value are not included in the above disclosures; such items include short- and long-term investment, deferred compensation and derivative financial instruments. Substantially all of these assets are considered to be Level 1 and substantially all of the Company's liabilities' fair value are considered Level 2, with the exception of derivative instruments which are considered Level 2 for both assets and liabilities.

Derivatives and Hedging. The Company is exposed to various market risks such as changes in foreign currency rates. The Company uses derivatives to manage risks related to changes in foreign currency exchange rates arising from international trade, foreign currency monetary asset and liability balances and investments in foreign subsidiaries. Refer to Note 15 of the consolidated financial statements included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2025 for further information.

Net Investment Hedges. The Company designates foreign currency forwards to hedge a portion of foreign investments in its EUR and BRL denominated operations. As of March 31, 2026, this included 28 EUR-USD and 14 BRL-USD foreign currency forward instruments. The Company uses the forward method to assess hedge effectiveness for its net investment hedges. Gains and losses on these instruments are initially recognized in our Statement of Other Comprehensive Income (Loss) and are reclassified out of AOCI into gain or loss on sale of investment when the hedged net investment is either sold or substantially liquidated. Cash flows from the net investment hedges are classified as Certain other assets and liabilities on the Statement of Cash Flows.
Non-Designated Hedges. The Company uses non-designated foreign exchange forward contracts with maturities of up to 12 months to mitigate the impact of currency fluctuations on foreign currency asset and liability balances. Forward-based gains/losses are classified as foreign exchange gain (loss), net on the Statement of Earnings. Cash flows from the foreign exchange forward contracts are classified as Certain other assets and liabilities on the Statement of Cash Flows.

Fair Value of Derivatives. The following table presents the fair value of our derivative instruments and identifies the statement of financial position line items in which these amounts are included. All fair values are presented on a gross basis, consistent with the Company's policy to not elect to net derivative assets and liabilities that are subject to master netting agreements:
March 31, 2026
Gross notionalOther current assetsOther current liabilities
Designated forward currency exchange contracts1
$575.6 $0.8 $(3.5)
Non-Designated forward exchange contracts2
$768.0 5.6 (2.8)
Net derivatives recognized in statement of financial position$6.4 $(6.3)
1 Gains (losses) in our Other comprehensive Income (loss) driven by net investment hedges was $3.0 for the three months ended March 31, 2026.
2 Gains (losses) in our Statement of Earnings (loss) driven by hedges of foreign exchange fluctuation was $(7.0) for the three months ended March 31, 2026. These amounts are offset by the remeasurement of the underlying exposure through foreign exchange gain or loss, net on the Statement of Earnings.
v3.26.1
Commitments, Guarantees, Product Warranties and Other Contingencies
3 Months Ended
Mar. 31, 2026
Commitments and Contingencies Disclosure [Abstract]  
Commitments, Guarantees, Product Warranties and Other Contingencies Commitments, Guarantees, Product Warranties and Other Contingencies. Indirect Tax Contingencies. At March 31, 2026, the Company was a party to several routine indirect tax claims from various taxing authorities globally that were incurred in the normal course of business, which neither individually nor in the aggregate are considered material by management in relation to the Company’s financial position or results of operations. In management’s opinion, the condensed consolidated financial statements would not be materially affected by the outcome of these indirect tax claims and/or proceedings or asserted claims.
Although management believes the Company has valid defenses with respect to its indirect tax positions, it is reasonably possible that a loss could occur in excess of the estimated liabilities. The Company estimated the aggregate risk at March 31, 2026 to be up to $52.5 for its material indirect tax matters. The aggregate risk related to indirect taxes is adjusted as the applicable statutes of limitations expire.

Legal Contingencies. At March 31, 2026, the Company was a party to several lawsuits that were incurred in the normal course of business, which neither individually nor in the aggregate were considered material by management in relation to the Company’s financial position or results of operations. In management’s opinion, the Company's condensed consolidated financial statements would not be materially affected by the outcome of these legal proceedings or asserted claims.

Refer to Note 16 of the consolidated financial statements included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2025.

Bank Guarantees, Standby Letters of Credit, and Surety Bonds. At March 31, 2026, the maximum future contractual obligations relative to performance guarantees totaled $128.9, of which $24.3 represented standby letters of credit to insurance providers, and no associated liability was recorded. At December 31, 2025, the maximum future payment obligations relative to these various guarantees totaled $130.8, of which $24.3 represented standby letters of credit to insurance providers, and no associated liability was recorded.

Product Warranties. The Company provides its customers a standard manufacturer’s warranty and records, at the time of the sale, a corresponding estimated liability for potential warranty costs. Estimated future obligations due to warranty claims are based upon historical factors such as labor rates, average repair time, travel time, number of service calls per machine and cost of replacement parts. Changes in the Company’s warranty liability balance are illustrated in the following table:
20262025
Beginning balance as of January 1$20.1 $22.5 
Current period accruals3.9 4.2 
Current period settlements(4.9)(6.5)
Currency translation adjustment(0.5)0.6 
Ending balance as of March 31
$18.6 $20.8 
Restricted Cash. The following table provides a reconciliation of Cash, cash equivalents and Short-term restricted cash reporting within the Company's Condensed Consolidated Statement of Financial Position and in the Condensed Consolidated Statements of Cash Flows:
March 31, 2026December 31, 2025
Cash and cash equivalents$358.6 $368.9 
Bank collateral guarantees7.3 10.7 
Pension collateral guarantees7.7 7.7 
Restricted cash and cash equivalents15.0 18.4 
Total cash, cash equivalents, and restricted cash$373.6 $387.3 
v3.26.1
Insider Trading Arrangements
3 Months Ended
Mar. 31, 2026
Trading Arrangements, by Individual  
Rule 10b5-1 Arrangement Adopted false
Non-Rule 10b5-1 Arrangement Adopted false
Rule 10b5-1 Arrangement Terminated false
Non-Rule 10b5-1 Arrangement Terminated false
v3.26.1
Inventories (Tables)
3 Months Ended
Mar. 31, 2026
Inventory Disclosure [Abstract]  
Schedule of Major Classes of Inventories Major classes of inventories are summarized as follows:
March 31, 2026December 31, 2025
Raw materials and work in process$181.2 $173.3 
Finished goods179.0 154.0 
Total product inventories360.2 327.3 
Service parts192.9 193.7 
Total inventories$553.1 $521.0 
v3.26.1
Property, Plant and Equipment and Operating Leases (Tables)
3 Months Ended
Mar. 31, 2026
Property, Plant and Equipment [Abstract]  
Schedule of Property, Plant and Equipment and Operating Leases
March 31, 2026December 31, 2025
Cost$224.8 $225.6 
Less accumulated depreciation(84.0)(81.0)
Right-of-use operating lease assets152.2 141.4 
Property, plant and equipment, net$293.0 $286.0 
v3.26.1
Goodwill and Other Intangible Assets (Tables)
3 Months Ended
Mar. 31, 2026
Goodwill and Intangible Assets Disclosure [Abstract]  
Schedule of Goodwill The changes in the carrying amount of goodwill for the three months ended March 31, 2026:
BankingRetailTotal
Goodwill, balance at January 1, 2026$490.9 $151.5 $642.4 
Currency translation adjustment(7.9)(2.4)(10.3)
Goodwill, balance at March 31, 2026
483.0 149.1 632.1 
Schedule of Intangible Assets
The following summarizes information on Intangible assets by major category:
March 31, 2026December 31, 2025
Weighted-average remaining useful livesGross
Carrying
Amount
Accumulated
Amortization
Net
Carrying
Amount
Gross
Carrying Amount
Accumulated
Amortization
Net
Carrying
Amount
Customer relationships14.9 years$575.4 $(86.7)$488.7 $584.7 $(79.5)$505.2 
Trademarks and trade names15.7 years121.7 (17.5)104.2 123.3 (16.0)107.3 
Capitalized software development2.0 years79.8 (22.4)57.4 75.6 (18.3)57.3 
Technology know-how and development costs non-software and other3.6 years237.8 (123.5)114.3 240.8 (118.2)122.6 
Customer relationships and other intangible assets, net$1,014.7 $(250.1)$764.6 $1,024.4 $(232.0)$792.4 
v3.26.1
Revenue Recognition (Tables)
3 Months Ended
Mar. 31, 2026
Revenue from Contract with Customer [Abstract]  
Schedule of Receivables and Deferred Revenue from Contracts with Customers The following table provides information about receivables and deferred revenue, which represent contract liabilities from contracts with customers:
Contract balance informationTrade receivablesContract liabilities
Balance at December 31, 2025$609.4 $325.8 
Balance at March 31, 2026$597.0 $359.4 
v3.26.1
Segment Information (Tables)
3 Months Ended
Mar. 31, 2026
Segment Reporting [Abstract]  
Schedule of Segment Information
The following tables present information regarding the Company’s segment performance and provide a reconciliation between segment operating profit and the consolidated income (loss) before taxes:
Three months ended March 31,
 20262025
Banking$620.7 $629.5 
Retail267.5 211.6 
Total net sales by segment$888.2 $841.1 
Banking455.6 468.1 
Retail207.1 159.8 
Total segment cost of sales$662.7 $627.9 
Banking165.1 161.5 
Retail60.4 51.7 
Total segment gross profit$225.5 $213.2 
Banking66.4 64.0 
Retail30.4 29.2 
Total segment SG&A and other operating expenses$96.8 $93.2 
Banking$98.7 $97.6 
Retail30.0 22.4 
Total segment operating profit$128.7 $120.0 
Corporate charges not allocated to segments(1)
$(67.8)$(72.1)
Restructuring and other saving initiative expenses(2)
(24.0)(20.0)
Non-core APMEA entity(3)
(6.7)— 
Net non-routine income(4)
2.5 1.7 
(96.0)(90.4)
Operating profit32.7 29.6 
Other expense, net(20.3)(37.0)
Income (loss) before taxes$12.4 $(7.4)
(1)    Corporate charges not allocated to segments include headquarter-based costs associated primarily with human resources, finance, IT and legal that are not directly attributable to a particular segment and are separately assessed by the CODM for purposes of making decisions.
(2)    Refer to Note 11 for further information regarding restructurings. Consistent with the historical reportable segment structure, restructuring and saving initiative costs are not assigned to the segments, and are separately analyzed by the CODM.
(3)    Non-core APMEA entity includes operational activity and impairment charges that the Company intends to wind down in 2026, including $3.6 of revenue for the three months ended March 31, 2026.
(4)    Net non-routine income consists of items that the Company has determined are non-routine in nature and not allocated to the reportable operating segments as they are not included in the measure used by the CODM to make decisions, allocate resources and assess performance.
Schedule of Revenue from External Customers by Product and Service Solution
The following table presents information regarding the Company’s segment net sales by service and product solution:
Three months ended March 31,
20262025
Services$391.1 $382.2 
Products233.1 247.3 
Total Banking624.2 629.5 
Services145.7 126.3 
Products121.9 85.3 
Total Retail267.6 211.6 
Total revenue $891.8 $841.1 
v3.26.1
Debt (Tables)
3 Months Ended
Mar. 31, 2026
Debt Disclosure [Abstract]  
Schedule of Outstanding Debt Balances Outstanding debt balances were as follows:
March 31, 2026December 31, 2025
2030 Senior Secured Notes$950.0 $950.0 
Other19.9 20.7 
Long-term debt$969.9 $970.7 
Long-term deferred financing fees(30.5)(32.2)
Total outstanding debt$939.4 $938.5 
Schedule of Financing Facilities
Below is a summary of financing information:
Financing FacilitiesInterest Rate
Index and Margin
Maturity/Termination DatesInitial Term (Years)
2030 Senior Secured Notes
7.75%
March 20305.25
Revolving Credit Facility(i)
SOFR + 2.75%-3.50%
December 20295.00
(i)SOFR with a floor of 0.0%
v3.26.1
Income Taxes (Tables)
3 Months Ended
Mar. 31, 2026
Income Tax Disclosure [Abstract]  
Schedule of Components of Income Tax Expense (Benefit)
Three months ended March 31,
20262025
Income tax expense
$5.7 $(2.2)
Effective tax rate46.0 %29.7 %
v3.26.1
Shareholders' Equity (Tables)
3 Months Ended
Mar. 31, 2026
Equity [Abstract]  
Schedule of Accumulated Other Comprehensive Income (Loss) The following table summarizes the changes in the Company’s Accumulated Other Comprehensive Income (AOCI), net of tax, by component for the three months ended March 31, 2026 and 2025:
Accumulated Other Comprehensive Income (Loss)Three months ended March 31,
(in millions)20262025
Beginning balance$74.5 $(111.6)
Other comprehensive income before reclassifications(1)
(27.7)70.0 
Currency translation adjustments AOCI$46.8 $(41.6)
Beginning balance$(6.0)$(0.1)
Other comprehensive loss before reclassifications2.2 — 
Foreign currency hedges AOCI$(3.8)$(0.1)
Beginning balance$10.1 $(5.7)
Amounts reclassified from AOCI(2)
0.7 (0.6)
Pension and other post-retirement benefits$10.8 $(6.3)
Beginning balance$(0.8)$(0.5)
Other comprehensive loss before reclassifications(0.3)(0.3)
Other$(1.1)$(0.8)
AOCI at March 31$52.7 $(48.8)
(1) Other comprehensive income (loss) before reclassifications within the translation component excludes $2.1 and $0.2 translation amount attributable to noncontrolling interests for the three months ended March 31, 2026 and 2025, respectively.
(2) The total reclassification from AOCI included pension and post-retirement net actuarial gain (loss) of $0.7 and $(0.6) net of tax, for the three months ended March 31, 2026 and 2025, respectively.
v3.26.1
Earnings (Loss) Per Share (Tables)
3 Months Ended
Mar. 31, 2026
Earnings Per Share [Abstract]  
Schedule of Earnings Per Share The following table represents amounts used in computing earnings per share and the effect on the weighted-average number of shares of potential dilutive common stock:
Three months ended March 31,
20262025
Earnings used in basic and diluted earnings per share
Net income (loss)$5.5 $(7.5)
Net income attributable to noncontrolling interests0.5 0.8 
Net income (loss) attributable to Diebold Nixdorf$5.0 $(8.3)
Weighted-average common shares in basic earnings (loss) per share35.1 37.6 
Effect of dilutive shares(1)
0.6 — 
Weighted-average number of shares used in diluted earnings (loss) per share 35.7 37.6 
Net income (loss) attributable to Diebold Nixdorf
Basic earnings (loss) per share$0.14 $(0.22)
Diluted (loss) earnings per share$0.14 $(0.22)
Anti-dilutive shares
Anti-dilutive shares not used in calculating diluted weighted-average shares— 0.5 
(1)     Shares of 0.3 for the three months ended March 31, 2025 are excluded from the computation of diluted loss per share because the effects are anti-dilutive, due to the net loss position.
v3.26.1
Restructuring (Tables)
3 Months Ended
Mar. 31, 2026
Restructuring and Related Activities [Abstract]  
Schedule of Restructuring and Related Costs
The following tables summarizes the impact of the Company’s restructuring charges on the Consolidated Statements of Earnings:
Three months ended March 31,
 20262025
Cost of sales – services$11.5 $10.5 
Cost of sales – products0.6 0.3 
Selling and administrative expense11.9 6.8 
Research, development and engineering expense— 2.4 
Total$24.0 $20.0 
Schedule of Restructuring Accrual Balances and Related Activity
The following table summarizes the Company’s severance accrual balance and related activity:
20262025
Beginning balance as of January 1$41.4 $15.9 
Severance accrual10.9 15.2 
Payout/Settlement(9.5)(11.0)
Other(0.1)0.1 
Ending balance as of March 31$42.7 $20.2 
v3.26.1
Financial Instruments and Fair Value (Tables)
3 Months Ended
Mar. 31, 2026
Financial Instruments and Fair Value [Abstract]  
Schedule of Assets and Liabilities Not Carried at Fair Value The following table provides information about assets and liabilities not carried at fair value and excludes asset and liabilities without readily determinable fair value.
 March 31, 2026December 31, 2025
 Carrying amountEstimated fair valueCarrying amount (net)Estimated fair value
LiabilitiesBorrowings (Note 7)$969.9 $1,007.9 $970.7 $1,030.1 
Schedule of Fair Value of Derivative Instruments The following table presents the fair value of our derivative instruments and identifies the statement of financial position line items in which these amounts are included. All fair values are presented on a gross basis, consistent with the Company's policy to not elect to net derivative assets and liabilities that are subject to master netting agreements:
March 31, 2026
Gross notionalOther current assetsOther current liabilities
Designated forward currency exchange contracts1
$575.6 $0.8 $(3.5)
Non-Designated forward exchange contracts2
$768.0 5.6 (2.8)
Net derivatives recognized in statement of financial position$6.4 $(6.3)
1 Gains (losses) in our Other comprehensive Income (loss) driven by net investment hedges was $3.0 for the three months ended March 31, 2026.
2 Gains (losses) in our Statement of Earnings (loss) driven by hedges of foreign exchange fluctuation was $(7.0) for the three months ended March 31, 2026. These amounts are offset by the remeasurement of the underlying exposure through foreign exchange gain or loss, net on the Statement of Earnings.
v3.26.1
Commitments, Guarantees, Product Warranties and Other Contingencies (Tables)
3 Months Ended
Mar. 31, 2026
Commitments and Contingencies Disclosure [Abstract]  
Schedule of Changes in Warranty Liability Balance Changes in the Company’s warranty liability balance are illustrated in the following table:
20262025
Beginning balance as of January 1$20.1 $22.5 
Current period accruals3.9 4.2 
Current period settlements(4.9)(6.5)
Currency translation adjustment(0.5)0.6 
Ending balance as of March 31
$18.6 $20.8 
Schedule of Cash and Cash Equivalents The following table provides a reconciliation of Cash, cash equivalents and Short-term restricted cash reporting within the Company's Condensed Consolidated Statement of Financial Position and in the Condensed Consolidated Statements of Cash Flows:
March 31, 2026December 31, 2025
Cash and cash equivalents$358.6 $368.9 
Bank collateral guarantees7.3 10.7 
Pension collateral guarantees7.7 7.7 
Restricted cash and cash equivalents15.0 18.4 
Total cash, cash equivalents, and restricted cash$373.6 $387.3 
v3.26.1
Inventories (Details) - USD ($)
$ in Millions
Mar. 31, 2026
Dec. 31, 2025
Major classes of inventories    
Raw materials and work in process $ 181.2 $ 173.3
Finished goods 179.0 154.0
Service parts 192.9 193.7
Total inventories 553.1 521.0
Products    
Major classes of inventories    
Total inventories $ 360.2 $ 327.3
v3.26.1
Property, Plant and Equipment and Operating Leases - Schedule of Property, Plant and Equipment and Operating Leases (Details) - USD ($)
$ in Millions
Mar. 31, 2026
Dec. 31, 2025
Property, Plant and Equipment [Abstract]    
Cost $ 224.8 $ 225.6
Less accumulated depreciation (84.0) (81.0)
Right-of-use operating lease assets 152.2 141.4
Property, plant and equipment, net $ 293.0 $ 286.0
v3.26.1
Property, Plant and Equipment and Operating Leases - Narrative (Details) - USD ($)
$ in Millions
3 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Dec. 31, 2025
Property, Plant and Equipment [Abstract]      
Depreciation $ 6.4 $ 8.5  
Operating lease liabilities, current 55.4   $ 51.8
Operating lease liabilities, noncurrent $ 98.8   $ 91.9
v3.26.1
Goodwill and Other Intangible Assets - Schedule of Goodwill (Details)
$ in Millions
3 Months Ended
Mar. 31, 2026
USD ($)
Goodwill [Roll Forward]  
Beginning balance $ 642.4
Currency translation adjustment (10.3)
Ending balance 632.1
Banking  
Goodwill [Roll Forward]  
Beginning balance 490.9
Currency translation adjustment (7.9)
Ending balance 483.0
Retail  
Goodwill [Roll Forward]  
Beginning balance 151.5
Currency translation adjustment (2.4)
Ending balance $ 149.1
v3.26.1
Goodwill and Other Intangible Assets - Schedule of Intangible Assets (Details) - USD ($)
$ in Millions
3 Months Ended
Mar. 31, 2026
Dec. 31, 2025
Finite-Lived Intangible Assets [Line Items]    
Gross Carrying Amount $ 1,014.7 $ 1,024.4
Accumulated Amortization (250.1) (232.0)
Net Carrying Amount $ 764.6 792.4
Customer relationships    
Finite-Lived Intangible Assets [Line Items]    
Weighted-average remaining useful lives 14 years 10 months 24 days  
Gross Carrying Amount $ 575.4 584.7
Accumulated Amortization (86.7) (79.5)
Net Carrying Amount $ 488.7 505.2
Trademarks and trade names    
Finite-Lived Intangible Assets [Line Items]    
Weighted-average remaining useful lives 15 years 8 months 12 days  
Gross Carrying Amount $ 121.7 123.3
Accumulated Amortization (17.5) (16.0)
Net Carrying Amount $ 104.2 107.3
Capitalized software development    
Finite-Lived Intangible Assets [Line Items]    
Weighted-average remaining useful lives 2 years  
Gross Carrying Amount $ 79.8 75.6
Accumulated Amortization (22.4) (18.3)
Net Carrying Amount $ 57.4 57.3
Technology know-how and development costs non-software and other    
Finite-Lived Intangible Assets [Line Items]    
Weighted-average remaining useful lives 3 years 7 months 6 days  
Gross Carrying Amount $ 237.8 240.8
Accumulated Amortization (123.5) (118.2)
Net Carrying Amount $ 114.3 $ 122.6
v3.26.1
Goodwill and Other Intangible Assets - Narrative (Details) - USD ($)
$ in Millions
3 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Goodwill and Intangible Assets Disclosure [Abstract]    
Amortization expense $ 25.0 $ 25.4
Intangible assets, decrease for currency translation 15.2  
Software development costs $ 5.4 $ 1.7
v3.26.1
Revenue Recognition - Schedule of Disaggregation of Revenue (Details) - USD ($)
$ in Millions
Mar. 31, 2026
Dec. 31, 2025
Revenue from Contract with Customer [Abstract]    
Trade receivables $ 597.0 $ 609.4
Contract liabilities $ 359.4 $ 325.8
v3.26.1
Revenue Recognition - Narrative (Details) - USD ($)
$ in Millions
3 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Dec. 31, 2025
Disaggregation of Revenue [Line Items]      
Impairment losses recognized as bad debt expense $ 0.6 $ 1.7  
Deferred revenue 359.4   $ 325.8
Deferred revenue, revenue recognized $ 102.8    
Transferred at Point in Time      
Disaggregation of Revenue [Line Items]      
Net sales, percentage 40.00% 40.00%  
Transferred over Time      
Disaggregation of Revenue [Line Items]      
Net sales, percentage 60.00% 60.00%  
v3.26.1
Segment Information - Schedule of Segment Information (Details) - USD ($)
$ in Millions
3 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Segment Reporting [Abstract]    
Number of reportable segments disclosed by definition flag reportable segment  
Segment Reporting Information [Line Items]    
Net sales $ 891.8 $ 841.1
Total cost of sales 678.7 638.7
Total segment gross profit 213.1 202.4
Total segment SG&A and other operating expenses 180.4 172.8
Operating profit 32.7 29.6
Other expense, net (20.3) (37.0)
Income (loss) before taxes 12.4 (7.4)
Banking    
Segment Reporting Information [Line Items]    
Net sales 624.2 629.5
Retail    
Segment Reporting Information [Line Items]    
Net sales 267.6 211.6
Operating Segments    
Segment Reporting Information [Line Items]    
Net sales 888.2 841.1
Total cost of sales 662.7 627.9
Total segment gross profit 225.5 213.2
Total segment SG&A and other operating expenses 96.8 93.2
Operating profit 128.7 120.0
Operating Segments | Banking    
Segment Reporting Information [Line Items]    
Net sales 620.7 629.5
Total cost of sales 455.6 468.1
Total segment gross profit 165.1 161.5
Total segment SG&A and other operating expenses 66.4 64.0
Operating profit 98.7 97.6
Operating Segments | Retail    
Segment Reporting Information [Line Items]    
Total cost of sales 207.1 159.8
Total segment gross profit 60.4 51.7
Total segment SG&A and other operating expenses 30.4 29.2
Operating profit 30.0 22.4
Operating Segments | Retail | Continuing Operations    
Segment Reporting Information [Line Items]    
Net sales 267.5 211.6
Corporate and segment reconciling items    
Segment Reporting Information [Line Items]    
Operating profit (96.0) (90.4)
Corporate, Non-Segment    
Segment Reporting Information [Line Items]    
Operating profit (67.8) (72.1)
Segment reconciling items | Restructuring and other saving initiative expenses    
Segment Reporting Information [Line Items]    
Operating profit (24.0) (20.0)
Segment reconciling items | Non-Core APMEA Entity    
Segment Reporting Information [Line Items]    
Operating profit (6.7) 0.0
Segment reconciling items | Net non-routine income    
Segment Reporting Information [Line Items]    
Operating profit 2.5 $ 1.7
Segment reconciling items | Wind down activity    
Segment Reporting Information [Line Items]    
Operating profit $ 3.6  
v3.26.1
Segment Information - Schedule of Revenue from External Customers by Products and Services (Details) - USD ($)
$ in Millions
3 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Segment Reporting Information [Line Items]    
Total net sales by segment $ 891.8 $ 841.1
Banking    
Segment Reporting Information [Line Items]    
Total net sales by segment 624.2 629.5
Retail    
Segment Reporting Information [Line Items]    
Total net sales by segment 267.6 211.6
Services    
Segment Reporting Information [Line Items]    
Total net sales by segment 536.8 508.5
Services | Banking    
Segment Reporting Information [Line Items]    
Total net sales by segment 391.1 382.2
Services | Retail    
Segment Reporting Information [Line Items]    
Total net sales by segment 145.7 126.3
Products    
Segment Reporting Information [Line Items]    
Total net sales by segment 355.0 332.6
Products | Banking    
Segment Reporting Information [Line Items]    
Total net sales by segment 233.1 247.3
Products | Retail    
Segment Reporting Information [Line Items]    
Total net sales by segment $ 121.9 $ 85.3
v3.26.1
Debt - Schedule of Outstanding Debt Balances (Details) - USD ($)
$ in Millions
Mar. 31, 2026
Dec. 31, 2025
Debt Instrument [Line Items]    
Long-term debt, gross $ 969.9 $ 970.7
Long-term deferred financing fees (30.5) (32.2)
Total outstanding debt 939.4 938.5
2030 Senior Secured Notes | Senior Notes    
Debt Instrument [Line Items]    
Long-term debt, gross 950.0 950.0
Other    
Debt Instrument [Line Items]    
Long-term debt, gross $ 19.9 $ 20.7
v3.26.1
Debt - 2024 Refinancing Activities (Details) - 2030 Senior Secured Notes - Senior Notes
$ in Millions
Dec. 18, 2024
USD ($)
Line of Credit Facility [Line Items]  
Principal amount $ 950.0
Interest rate 7.75%
v3.26.1
Debt - Revolving Credit Agreement (Details) - Line of Credit - Revolving Facility - USD ($)
3 Months Ended
Dec. 18, 2024
Mar. 31, 2026
2029 Revolving Facility    
Line of Credit Facility [Line Items]    
Line of credit facility, maximum borrowing capacity $ 310,000,000.0  
2029 Revolving Facility | Minimum    
Line of Credit Facility [Line Items]    
Basis spread rate   2.75%
2029 Revolving Facility | Maximum    
Line of Credit Facility [Line Items]    
Basis spread rate   3.50%
Revolving Credit Facility 2029 | Minimum | Secured Overnight Financing Rate (SOFR)    
Line of Credit Facility [Line Items]    
Basis spread rate 2.75%  
Revolving Credit Facility 2029 | Minimum | Base Rate    
Line of Credit Facility [Line Items]    
Basis spread rate 1.75%  
Revolving Credit Facility 2029 | Maximum | Secured Overnight Financing Rate (SOFR)    
Line of Credit Facility [Line Items]    
Basis spread rate 3.50%  
Revolving Credit Facility 2029 | Maximum | Base Rate    
Line of Credit Facility [Line Items]    
Basis spread rate 2.50%  
v3.26.1
Debt - Schedule of Financing Facilities (Details)
3 Months Ended
Mar. 31, 2026
2030 Senior Secured Notes | Senior Notes  
Short-term Debt [Line Items]  
Basis spread rate 7.75%
Initial Term (Years) 5 years 3 months
2029 Revolving Facility | Revolving Facility | Line of Credit  
Short-term Debt [Line Items]  
Initial Term (Years) 5 years
Floor rate percentage 0.00%
2029 Revolving Facility | Minimum | Revolving Facility | Line of Credit  
Short-term Debt [Line Items]  
Basis spread rate 2.75%
2029 Revolving Facility | Maximum | Revolving Facility | Line of Credit  
Short-term Debt [Line Items]  
Basis spread rate 3.50%
v3.26.1
Debt - Line of Credit (Details) - Various short-term lines of credit - USD ($)
$ in Millions
3 Months Ended
Mar. 31, 2026
Dec. 31, 2025
Line of Credit Facility [Line Items]    
Borrowing capacity under credit facility $ 14.5 $ 8.5
Line of credit facility expiration period 1 year  
v3.26.1
Income Taxes - Schedule of Components of Income Tax Expense (Benefit) (Details) - USD ($)
$ in Millions
3 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Income Tax Disclosure [Abstract]    
Income tax expense $ 5.7 $ (2.2)
Effective tax rate 46.00% 29.70%
v3.26.1
Income Taxes - Narrative (Details)
3 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Income Tax Disclosure [Abstract]    
Effective tax rate 46.00% 29.70%
v3.26.1
Shareholders' Equity - Schedule of Accumulated Other Comprehensive Income (Loss) (Details) - USD ($)
$ in Millions
3 Months Ended
Mar. 31, 2026
Mar. 31, 2025
AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax [Roll Forward]    
Beginning balance $ 1,104.8  
Ending balance 1,026.2 $ 991.0
Foreign currency hedges    
AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax [Roll Forward]    
Other comprehensive income (loss) before reclassifications 2.2 0.0
AOCI Attributable to Parent    
AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax [Roll Forward]    
Beginning balance 77.8 (117.9)
Ending balance 52.7 (48.8)
Currency translation adjustments AOCI    
AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax [Roll Forward]    
Beginning balance 74.5 (111.6)
Other comprehensive income (loss) before reclassifications (27.7) 70.0
Ending balance 46.8 (41.6)
Hedges AOCI | Foreign currency hedges    
AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax [Roll Forward]    
Beginning balance (6.0) (0.1)
Other comprehensive income (loss) before reclassifications 2.2 0.0
Ending balance (3.8) (0.1)
Pension and other post-retirement benefits    
AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax [Roll Forward]    
Beginning balance 10.1 (5.7)
Ending balance 10.8 (6.3)
Net actuarial gain (loss)    
AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax [Roll Forward]    
Amounts reclassified from AOCI 0.7 (0.6)
Other    
AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax [Roll Forward]    
Beginning balance (0.8) (0.5)
Other comprehensive income (loss) before reclassifications (0.3) (0.3)
Ending balance (1.1) (0.8)
Foreign currency hedges AOCI attributable to noncontrolling interests    
AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax [Roll Forward]    
Other comprehensive income (loss) before reclassifications $ 2.1 $ 0.2
v3.26.1
Shareholders' Equity - Narrative (Details) - USD ($)
$ / shares in Units, $ in Millions
3 Months Ended
Mar. 31, 2026
Dec. 31, 2025
Equity [Abstract]    
Common stock, shares authorized (in shares) 45,000,000  
Common stock, par or stated value per share (in dollars per share) $ 0.01  
Common stock, shares, issued (in shares) 37,900,756 37,726,003
Common stock, shares, outstanding (in shares) 34,751,349 35,384,690
Treasury shares (in shares) 3,149,407 2,341,313
Stock repurchased (in shares) 747,000  
Stock repurchased value $ 55.0  
Stock repurchased, taxes and fees $ 0.6  
Shares withheld for income taxes on vested share-based compensation (in shares) 61,484  
Shares withheld for income taxes on vested share-based compensation $ 4.8  
v3.26.1
Earnings (Loss) Per Share (Details) - USD ($)
$ / shares in Units, shares in Millions, $ in Millions
3 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Earnings used in basic and diluted earnings per share    
Net income (loss) $ 5.5 $ (7.5)
Net income attributable to noncontrolling interests 0.5 0.8
Net income (loss) attributable to Diebold Nixdorf $ 5.0 $ (8.3)
Weighted-average common shares in basic earnings (loss) per share (in shares) 35.1 37.6
Effect of dilutive shares (in shares) 0.6 0.0
Weighted-average number of shares used in diluted earnings (loss) per share (in shares) 35.7 37.6
Net income (loss) attributable to Diebold Nixdorf    
Basic earnings (loss) per share (in dollars per share) $ 0.14 $ (0.22)
Diluted (loss) earnings per share (in dollars per share) $ 0.14 $ (0.22)
Anti-dilutive shares    
Anti-dilutive shares not used in calculating diluted weighted-average shares (in shares) 0.0 0.5
Shares excluded from computation of diluted loss per share due to net loss position (in shares)   0.3
v3.26.1
Restructuring - Narrative (Details) - USD ($)
$ in Millions
3 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Dec. 31, 2025
Restructuring Cost and Reserve [Line Items]      
Restructuring charges $ 24.0 $ 20.0  
Operational Evolution Program (OEP)      
Restructuring Cost and Reserve [Line Items]      
Expected costs to be incurred     $ 95.0
Cumulative restructuring charges 50.9    
Operational Evolution Program (OEP) | Banking      
Restructuring Cost and Reserve [Line Items]      
Expected costs to be incurred     28.0
Cumulative restructuring charges 16.0    
Restructuring charges 6.0    
Operational Evolution Program (OEP) | Retail      
Restructuring Cost and Reserve [Line Items]      
Expected costs to be incurred     $ 17.0
Cumulative restructuring charges 9.0    
Restructuring charges $ 6.1    
Continuous Improvement Initiative | Banking      
Restructuring Cost and Reserve [Line Items]      
Restructuring charges   3.4  
Continuous Improvement Initiative | Retail      
Restructuring Cost and Reserve [Line Items]      
Restructuring charges   $ 7.1  
v3.26.1
Restructuring - Schedule of Restructuring and Related Costs (Details) - USD ($)
$ in Millions
3 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Schedule of restructuring and related costs    
Severance accrual $ 24.0 $ 20.0
Selling and administrative expense    
Schedule of restructuring and related costs    
Severance accrual 11.9 6.8
Research, development and engineering expense    
Schedule of restructuring and related costs    
Severance accrual 0.0 2.4
Services    
Schedule of restructuring and related costs    
Severance accrual 11.5 10.5
Products    
Schedule of restructuring and related costs    
Severance accrual $ 0.6 $ 0.3
v3.26.1
Restructuring - Schedule of Restructuring Accrual Balances and Related Activity (Details) - USD ($)
$ in Millions
3 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Restructuring Reserve [Roll Forward]    
Beginning balance $ 41.4 $ 15.9
Severance accrual 10.9 15.2
Payout/Settlement (9.5) (11.0)
Other (0.1) 0.1
Ending balance $ 42.7 $ 20.2
v3.26.1
Financial Instruments and Fair Value - Schedule of Assets and Liabilities Not Carried at Fair Value (Details) - USD ($)
$ in Millions
Mar. 31, 2026
Dec. 31, 2025
Carrying amount    
Derivative [Line Items]    
Borrowings (Note 7) $ 969.9 $ 970.7
Estimated fair value    
Derivative [Line Items]    
Borrowings (Note 7) $ 1,007.9 $ 1,030.1
v3.26.1
Financial Instruments and Fair Value - Narrative (Details)
Mar. 31, 2026
instrument
Foreign currency forward, EUR-USD  
Derivative [Line Items]  
Number of instruments held 28
Foreign currency forward, BRL-USD  
Derivative [Line Items]  
Number of instruments held 14
v3.26.1
Financial Instruments and Fair Value - Schedule of Fair Value of Derivative Instruments (Details)
$ in Millions
3 Months Ended
Mar. 31, 2026
USD ($)
Derivative [Line Items]  
Gross notional
Other comprehensive income (loss) driven by net investment hedges 3.0
Gains (losses) driven by hedges of foreign exchange fluctuation (7.0)
Other current assets  
Derivative [Line Items]  
Derivative assets 6.4
Other current liabilities  
Derivative [Line Items]  
Derivative liabilities (6.3)
Designated forward currency exchange contracts  
Derivative [Line Items]  
Gross notional 575.6
Designated forward currency exchange contracts | Other current assets  
Derivative [Line Items]  
Derivative assets 0.8
Designated forward currency exchange contracts | Other current liabilities  
Derivative [Line Items]  
Derivative liabilities (3.5)
Non-Designated forward exchange contracts  
Derivative [Line Items]  
Gross notional 768.0
Non-Designated forward exchange contracts | Other current assets  
Derivative [Line Items]  
Derivative assets 5.6
Non-Designated forward exchange contracts | Other current liabilities  
Derivative [Line Items]  
Derivative liabilities $ (2.8)
v3.26.1
Commitments, Guarantees, Product Warranties and Other Contingencies - Narrative (Details) - USD ($)
$ in Millions
Mar. 31, 2026
Dec. 31, 2025
Loss Contingencies [Line Items]    
Guarantor obligations, maximum exposure, undiscounted $ 128.9 $ 130.8
Guarantor obligations, liability 0.0 0.0
Financial Standby Letter of Credit    
Loss Contingencies [Line Items]    
Guarantor obligations, maximum exposure, undiscounted 24.3 $ 24.3
Indirect Tax Liability    
Loss Contingencies [Line Items]    
Range of possible loss, portion not accrued $ 52.5  
v3.26.1
Commitments, Guarantees, Product Warranties and Other Contingencies - Schedule of Changes in Warranty Liability Balance (Details) - USD ($)
$ in Millions
3 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Changes in warranty liability balance    
Beginning balance $ 20.1 $ 22.5
Current period accruals 3.9 4.2
Current period settlements (4.9) (6.5)
Currency translation adjustment (0.5) 0.6
Ending balance $ 18.6 $ 20.8
v3.26.1
Commitments, Guarantees, Product Warranties and Other Contingencies - Schedule of Cash and Cash Equivalents (Details) - USD ($)
$ in Millions
Mar. 31, 2026
Dec. 31, 2025
Mar. 31, 2025
Dec. 31, 2024
Commitments and Contingencies Disclosure [Abstract]        
Cash and cash equivalents $ 358.6 $ 368.9    
Bank collateral guarantees 7.3 10.7    
Pension collateral guarantees 7.7 7.7    
Restricted cash and cash equivalents 15.0 18.4    
Total cash, cash equivalents, and restricted cash $ 373.6 $ 387.3 $ 320.2 $ 311.3